Improving the quality of care in the molecular era for children and adolescents with medulloblastoma.
T de RojasM PuertasF BautistaI de PradaM Á López-PinoB RiveroC Gonzalez-San SegundoM Gonzalez-VicentA LassalettaL MaderoLucas MorenoPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2019)
This real-world research study resulted in the development of a pragmatic set of QIs, aimed to improve clinical audits and quality of care given to children and adolescents with medulloblastoma. We hope that our findings will serve as a reference to further develop a quality assurance system with specific QIs for pediatric CNS tumors in the future and that this will ultimately improve the survival and quality of life of these patients.
Keyphrases